Examination of ChIP-seq data from neuroblastoma cells (GSE13829553) identifies a significant MYC binding peak within the CDCA3 promoter region (Fig. 8B) [35], further supported by JASPAR database predictions of a potential E-box sequence in this region (Fig. 8C, D). The gene discussed is CDCA3; the disease is neuroblastoma.